315 related articles for article (PubMed ID: 34403963)
21. Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of "Neo-Islets," Three-Dimensional Aggregates of Allogeneic Islet and "Mesenchymal Stem Cells".
Westenfelder C; Gooch A; Hu Z; Ahlstrom J; Zhang P
Stem Cells Transl Med; 2017 Jul; 6(7):1631-1643. PubMed ID: 28467694
[TBL] [Abstract][Full Text] [Related]
22. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
Front Immunol; 2018; 9():1078. PubMed ID: 29892282
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases.
Chen X; Wang S; Cao W
Cell Immunol; 2018 Apr; 326():8-14. PubMed ID: 28778534
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells differentially mediate regulatory T cells and conventional effector T cells to protect fully allogeneic islet grafts in mice.
Xu DM; Yu XF; Zhang D; Zhang MX; Zhou JF; Tan PH; Ding YC
Diabetologia; 2012 Apr; 55(4):1091-102. PubMed ID: 22270222
[TBL] [Abstract][Full Text] [Related]
25. Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus.
Qu Z; Lou Q; Cooper DKC; Pu Z; Lu Y; Chen J; Ni Y; Zhan Y; Chen J; Li Z; Zhan N; Zeng Y; Tu Z; Cao H; Dai Y; Cai Z; Mou L
Xenotransplantation; 2021 May; 28(3):e12678. PubMed ID: 33569837
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9.
Ding Y; Xu D; Feng G; Bushell A; Muschel RJ; Wood KJ
Diabetes; 2009 Aug; 58(8):1797-806. PubMed ID: 19509016
[TBL] [Abstract][Full Text] [Related]
27. Research Status of Mesenchymal Stem Cells in Liver Transplantation.
You Y; Wen DG; Gong JP; Liu ZJ
Cell Transplant; 2019 Dec; 28(12):1490-1506. PubMed ID: 31512503
[TBL] [Abstract][Full Text] [Related]
28. Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells.
Li FR; Wang XG; Deng CY; Qi H; Ren LL; Zhou HX
Clin Exp Immunol; 2010 Aug; 161(2):357-63. PubMed ID: 20456412
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cells derived from human dental follicle modulate the aberrant immune response in atopic dermatitis.
Zibandeh N; Genc D; Ozgen Z; Duran Y; Goker K; Baris S; Ergun T; Akkoc T
Immunotherapy; 2021 Jul; 13(10):825-840. PubMed ID: 33955241
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal Stem Cell in Pancreatic Islet Transplantation.
Barachini S; Biso L; Kolachalam S; Petrini I; Maggio R; Scarselli M; Longoni B
Biomedicines; 2023 May; 11(5):. PubMed ID: 37239097
[TBL] [Abstract][Full Text] [Related]
31. Protecting islet functional viability using mesenchymal stromal cells.
Hubber EL; Rackham CL; Jones PM
Stem Cells Transl Med; 2021 May; 10(5):674-680. PubMed ID: 33544449
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulatory effect of mesenchymal stem cells in chemical-induced liver injury: a high-dimensional analysis.
Liu J; Feng B; Xu Y; Zhu J; Feng X; Chen W; Sheng X; Shi X; Pan Q; Yu J; Zeng X; Cao H; Li L
Stem Cell Res Ther; 2019 Aug; 10(1):262. PubMed ID: 31443686
[TBL] [Abstract][Full Text] [Related]
33. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Le Blanc K; Ringdén O
Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
[TBL] [Abstract][Full Text] [Related]
34. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
35. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
Cheng X; Jiang M; Long L; Meng J
Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
[No Abstract] [Full Text] [Related]
36. Effect of hTIMP-1 overexpression in human umbilical cord mesenchymal stem cells on the repair of pancreatic islets in type-1 diabetic mice.
Bao Y; Zhao Z; Gao H
Cell Biol Int; 2021 May; 45(5):1038-1049. PubMed ID: 33404139
[TBL] [Abstract][Full Text] [Related]
37. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.
Reading JL; Yang JH; Sabbah S; Skowera A; Knight RR; Pinxteren J; Vaes B; Allsopp T; Ting AE; Busch S; Raber A; Deans R; Tree TI
J Immunol; 2013 May; 190(9):4542-52. PubMed ID: 23547116
[TBL] [Abstract][Full Text] [Related]
38. Using Mesenchymal Stromal Cells in Islet Transplantation.
Arzouni AA; Vargas-Seymour A; Nardi N; J F King A; Jones PM
Stem Cells Transl Med; 2018 Aug; 7(8):559-563. PubMed ID: 29749717
[TBL] [Abstract][Full Text] [Related]
39. Co-transplantation of Xenogeneic Bone Marrow-derived Mesenchymal Stem Cells Alleviates Rejection of Pancreatic Islets in Non-obese Diabetic Mice.
Corradi-Perini C; Santos TM; Camara NOS; Riella MC; Aita CAM
Transplant Proc; 2017 May; 49(4):902-905. PubMed ID: 28457422
[TBL] [Abstract][Full Text] [Related]
40. Potential surrogate quantitative immunomodulatory potency assay for monitoring human umbilical cord-derived mesenchymal stem cells production.
Teng SW; Sung HY; Wen YC; Chen SY; Lovel R; Chang WY; Wu TB; Hsuan YC; Lin W
Cell Biol Int; 2021 May; 45(5):1072-1081. PubMed ID: 33470478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
